期刊文献+

顺铂肾损伤中血管紧张素Ⅱ与转化生长因子-β_1的作用及相关性研究

Study on Correlation between Ang Ⅱ and TGF-β_1 in Cisplatin Induced Renal Injury
下载PDF
导出
摘要 目的观察血管紧张素Ⅱ(AngⅡ)与转化生长因子-β1(TGF-β1)在顺铂肾损伤中的作用及二者的相关性。方法取16只大鼠随机分为正常组和模型组,各8只。采用尾静脉注射的方法复制顺铂肾损伤模型,6周后以放射免疫法检测肾组织中AngⅡ水平,免疫组化法观察TGF-β1在肾组织中的表达。结果与正常组比较,模型组肾组织中AngⅡ含量明显增加,TGF-β1在肾小管上皮细胞的表达明显增强(P<0.01),且二者之间有一定相关性(Y=0.138 X+0.062 8,r=0.98)。结论肾脏局部AngⅡ的水平与TGF-β1的表达可能在顺铂肾损伤的发生、发展中起一定作用,且二者呈正相关。 Objective To explore the role of angiotensin(AngⅡ) and transforming growth factor-β1 (TGF-β1) on cisplatin induced renal injury and their correlation.Methods 16 rats were randomly divided into the two groups,normal group and model group.The caudal vein injection was adopted to duplicate the cisplatin induced renal injury model in rat.The level of Ang Ⅱ in the renal tissue after 6 weeks was detected by radioimmunoassay and the expression of TGF-β1 in the renal tissue was observed by the immunohistochem-istry method.Results Compared with the blank group,the level of Ang Ⅱ in the model group was significantly increased and the ex-pression of TGF-β1 in the tubular epithelia was obviously enhanced(P〈0.01),moreover certain correlation existed between them(Y=0.138X+0.062 8,r=0.98).Conclusion The AngⅡ level and TGF-β1 expression may play a certain role in the occurrence and development of cisplatin induced renal injury and show the positive correlation.
出处 《中国药业》 CAS 2015年第7期34-35,共2页 China Pharmaceuticals
关键词 顺铂 肾损伤 血管紧张素Ⅱ 转化生长因子-Β1 相关性 cisplatin renal injury angiotensinⅡ transforming growth factor-β1 correlation
  • 相关文献

参考文献10

二级参考文献46

  • 1戴兵,梅长林.透析高血压的发病机制及治疗进展[J].中国血液净化,2007,6(1):5-7. 被引量:34
  • 2何新霞,韩卫红,薛燕,王红燕,王乐.血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂对糖尿病肾病患者肾功能的保护作用[J].中国慢性病预防与控制,2007,15(1):34-35. 被引量:18
  • 3Goldstein RS, Mayor GH. The nephrotoxicity of cisplatin. Life science, 1983,32 : 685 -690.
  • 4Coulombe J J, Favreall L. A new simple semimicro method for colometric determination of urea. Clin Chem, 1963,9:102.
  • 5Kintzel PE. Anticancer drug indueed kindney disorders. Drug Saf, 2001,24: 19-38.
  • 6RAM C V, FENVES A Z. Management of hypertension in hemodi- alysis patients [ J ]. Curr Hypertens Rep, 2009, 11 (4) : 292 - 298.
  • 7CHOU K J, LEE P T, CHEN C L, et al. Physiological changes during hemodialysis in patients with intradialysis hypertension [ J ]. Kidney Int, 2006, 69 (10) : 1833 -1838.
  • 8HORL M P. Hemodialysis - associated hypertension: pathophysiolo- gy and therapy[J]. Am J Kidney Dis, 2002, 39(2) : 227 -244.
  • 9SUZUKI H, KANNO Y, SUGAHARA S, et, al. Effect of angio-tensin receptor blockers on cardiovascular events in patients under- going hemodialysis: an open -label randomized controlled trial [J]. Am J Kidney Dis, 2008., 52(3) : 501 -506.
  • 10GOLDSMITH D J, COVIC A. Blood pressure in dialysis patients - look before we leap[J]. Lancet, 2009, 373(9679) : 1945.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部